Inflammatory mechanisms mediated by prostaglandins may contribute to the progression of intracerebral hemorrhage (ICH)-induced brain injury, but they are not fully understood. In this study, we examined the effect of prostaglandin E 2 receptor EP1 (EP1R) activation and inhibition on brain injury in mouse models of ICH and investigated the underlying mechanism of action. ICH was induced by injecting collagenase, autologous blood, or thrombin into the striatum of middle-aged male and female mice and aged male mice. Effects of selective EP1R agonist ONO-DI-004, antagonist SC51089, and nonspecific Src family kinase inhibitor PP2 were evaluated by a combination of histologic, magnetic resonance imaging (MRI), immunofluorescence, molecular, cellular, and behavioral assessments. EP1R was expressed primarily in neurons and axons but not in astrocytes or microglia after ICH induced by collagenase. In middle-aged male mice subjected to collagenase-induced ICH, EP1R inhibition mitigated brain injury, brain edema, cell death, neuronal degeneration, neuroinflammation, and neurobehavioral deficits, whereas its activation exacerbated these outcomes. EP1R inhibition also was protective in middle-aged female mice and aged male mice after collagenase-induced ICH and in middle-aged male mice after blood-or thrombin-induced ICH. EP1R inhibition also reduced oxidative stress, white matter injury, and brain atrophy and improved functional outcomes. Histologic results were confirmed by MRI. Src kinase phosphorylation and matrix metalloproteinase-9 activity were increased by EP1R activation and decreased by EP1R inhibition. EP1R regulated matrix metalloproteinase-9 activity through Src kinase signaling, which mediated EP1R toxicity after collagenase-induced ICH. We conclude that prostaglandin E 2 EP1R activation plays a toxic role after ICH through mechanisms that involve the Src kinases and the matrix metalloproteinase-9 signaling pathway. EP1R inhibition could be a novel therapeutic strategy to improve outcomes after ICH.
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Introduction
Spontaneous intracerebral hemorrhage (ICH) is a devastating type of stroke. It causes brain damage through many mechanisms. Hematoma formation and expansion within the brain cause the primary, mechanical damage. Inflammatory cascades, including those mediated by certain prostaglandins, contribute to the progression of secondary injury (Keep et al., 2012; Wang, 2010; Wu et al., 2010) , which causes severe neurologic deficits in patients. Interventions are needed that can limit detrimental effects of neuroinflammation on brain function and improve outcomes after ICH.
Prostaglandin E 2 (PGE 2 ) is predominant in the brain. This bioactive lipid is synthesized from cyclooxygenases and PGE 2 synthases. We and others have reported that the expression of cyclooxygenase-2 and microsomal PGE 2 synthase-1 is increased after ICH (Gong et al., 2001; Wu et al., 2011b) . Consequently, PGE 2 accumulates in the perihematomal region after ICH (Chu et al., 2004 
